NEMT Acquisition: What Brokers Won't Always Tell You

Non-emergency medical transportation is one of the verticals at the top of my acquisition list. Local, regulated, contract-driven, and rewarded by operating discipline. But the diligence has traps that brokers rarely surface up front, and learning about them after a term sheet is a painful way to learn.

The contract concentration question

NEMT revenue typically comes from two or three sources: state Medicaid programs (often through transportation brokers like ModivCare, Access2Care, or LogistiCare), managed care organizations, and a smaller fraction of private-pay or VA work. I want to see the contract mix in detail.

A business with eighty percent of revenue tied to a single Medicaid broker contract, on a three-year term with two years remaining, is a different deal than its trailing twelve EBITDA suggests. The renewal risk lives off the income statement, but it is the most important number in the diligence.

The reimbursement rate trend

Medicaid reimbursement rates change at the state level, sometimes annually, sometimes after a budget cycle. I want to see the rate history over the last four years for every contract that matters. If rates have been flat while the operator's costs have risen, the business is quietly compressing on margin in a way that will continue.

The credentialing and compliance question

NEMT is regulated. Drivers need clean MVRs, current first-aid certifications, and sometimes additional state-specific credentials. I always ask: what is the credentialing process, who owns it, what is the audit history, and what would happen tomorrow if a state-level audit found half the drivers out of compliance?

If the answer is unclear, the business is one audit away from a major operating disruption.

The fleet utilization picture

NEMT economics are utilization economics. I want trips per vehicle per day, deadhead miles as a fraction of total miles, scheduled-versus-completed trip rates, and the trend on each over the last two years. Lower utilization is a fixable problem. Falling utilization while trying to sell the business is a flag worth pulling on.

Why I still want to be in NEMT

Despite all of this, NEMT remains one of the strongest verticals for operator-led capital. Demographics support it. Reimbursement complexity creates a moat that protects disciplined operators. Regional consolidation opportunities are real. And the work itself is something I am proud to be involved in.

The right deal in this category is hard to find. That is exactly why it is worth the diligence to find it.